The use of sorafenib with insulin in all cases blocked the increase in VEGF content caused by diabetes (see Figure 1) – the content of this growth factor in the retina did not differ from the baseline data (p>0,05). The gene discussed is VEGFA; the disease is diabetes mellitus.